Impurities mix helps meet the new limits in pharmaceutical products for arsenic, cadmium, lead, and mercury

The new guidelines set by the United States Pharmacopeia (USP) have pushed the pharmaceutical and nutraceutical industries to provide accurate, quantifiable results for metal analysis in drugs, pharmaceutical substances, and raw materials.

USP <232> outlines new limits in pharmaceutical products for arsenic, cadmium, lead, and mercury. The procedures focus on the use of ICP-MS for the analysis of low level impurities. ICP-MS instrumentation, along with accurate ICP-MS standards, allow for increased efficiency and accuracy of the analysis necessary to comply with the new regulations.

Use these standards as a calibration or check standard to verify Oral Daily Dose PDE, Parenteral Component Limit, or Parenteral Daily Dose PDE as well as Inhalation Component Limit or Daily Dose.

Chemicals sold by Cole-Parmer are not intended for and should not be (i) used for medical, surgical or other patient oriented applications, or (ii) combined with any food product or ingested in any form.

This multi-component standard contains 5 components.

• Precious Metal Impurities B without Os is a 125 mL bottle which contains 100 mg/kg of Iridium, Palladium, Platinum, Rhodium, and Ruthenium.

Hazardous material shipping fees may apply.

• Use with ICP-MS instrumentation for the analysis of low level impurities|Manufactured under ISO 9001, ISO/IEC 17025 and ISO 17034 compliance

• Precious metal impurities B without Osmium (Os) in 15% HCl matrix|125 mL bottle